cART and Supportive Care for HIV-Associated Malignancies
作者： Ronald T. Mitsuyasu
DOI: 10.1007/978-1-4939-0859-2_27
关键词: Internal medicine 、 Antiretroviral therapy 、 Cart 、 Oncology 、 Medicine 、 Antibiotics 、 Tolerability 、 Regimen 、 Human immunodeficiency virus (HIV) 、 Standard treatment 、 Hematopoietic growth factor
摘要: cART is an abbreviation for combined antiretroviral therapy and generally refers to a three- or four-drug combination regimen of medications, which considered standard treatment human immunodeficiency virus-1 (HIV-1) infection. Another name highly active (HAART). This important suppressing HIV-1 replication has greatly increased the longevity individuals with this As part malignancies in HIV-infected patients, other supportive measures such as antiemetics, hematopoietic growth factors, blood transfusions, prophylactic therapeutic antibiotics, anti-diarrheal psycho-social support each individual undergoing stressful these often life-threatening cancers have enhanced both efficacy tolerability treatments allowed patients achieve remissions and/or cure their cancers.
springer.com
sci-hub.st 参考文章(19)
Lee Ratner, Jeannette Lee, Shenghui Tang, David Redden, Fayez Hamzeh, Brian Herndier, David Scadden, Lawrence Kaplan, Richard Ambinder, Alexandra Levine, William Harrington, Louise Grochow, Charles Flexner, Benjamin Tan, David Straus, Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy Journal of Clinical Oncology. ,vol. 19, pp. 2171- 2178 ,(2001) , 10.1200/JCO.2001.19.8.2171
L D Kaplan, J O Kahn, S Crowe, D Northfelt, P Neville, H Grossberg, D I Abrams, J Tracey, J Mills, P A Volberding, Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. Journal of Clinical Oncology. ,vol. 9, pp. 929- 940 ,(1991) , 10.1200/JCO.1991.9.6.929
Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, Joseph A Sparano, Ethel Cesarman, Amy Chadburn, Alexandra M Levine, David T Scadden, Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010 Blood. ,vol. 106, pp. 1538- 1543 ,(2005) , 10.1182/BLOOD-2005-04-1437
Dan L. Longo, Ronald G. Steis, H. Clifford Lane, Michael T. Lotze, Steven A. Rosenberg, Olivia Preble, Henry Masur, Alain H. Rook, Anthony S. Fauci, Joan Jacob, Edward P. Gelmann, MALIGNANCIES IN THE AIDS PATIENT: NATURAL HISTORY, TREATMENT STRATEGIES, AND PRELIMINARY RESULTS Annals of the New York Academy of Sciences. ,vol. 437, pp. 421- 430 ,(1984) , 10.1111/J.1749-6632.1984.TB37163.X
Alain Makinson, Jean-Louis Pujol, Vincent Le Moing, Helene Peyriere, Jacques Reynes, Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer. Journal of Thoracic Oncology. ,vol. 5, pp. 562- 571 ,(2010) , 10.1097/JTO.0B013E3181D3CCF2
DouglasW. Wilmore, BasilA. Pruitt, Fat boys get burned. The Lancet. ,vol. 2, pp. 631- 632 ,(1972) , 10.1016/S0140-6736(72)93020-6
Frantz Thiessard, Philippe Morlat, Catherine Marimoutou, Eric Labouyrie, Jean-Marie Ragnaud, Jean-Luc Pellegrin, Michel Dupon, Fran�ois Dabis, , Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus Cancer. ,vol. 88, pp. 1696- 1702 ,(2000) , 10.1002/(SICI)1097-0142(20000401)88:7<1696::AID-CNCR25>3.0.CO;2-L
John L. Ziegler, Jay A. Beckstead, Paul A. Volberding, Donald I. Abrams, Alexandra M. Levine, Robert J. Lukes, Parkash S. Gill, Ronald L. Burkes, Paul R. Meyer, Craig E. Metroka, Janet Mouradian, Anne Moore, Shirley A. Riggs, James J. Butler, Fernando C. Cabanillas, Evan Hersh, Guy R. Newell, Linda J. Laubenstein, Daniel Knowles, Chrystia Odajnyk, Bruce Raphael, Benjamin Koziner, Carlos Urmacher, Bayard D. Glarkson, Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome The New England Journal of Medicine. ,vol. 311, pp. 565- 570 ,(1984) , 10.1056/NEJM198408303110904
David T. Scadden, Harriet A. Bering, James D. Levine, Jocelyn Bresnahan, Lydia Evans, Carol Epstein, Jerome E. Groopman, GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-α in the treatment of AIDS-associated Kaposi's sarcoma American Journal of Clinical Oncology. ,vol. 14, ,(1991) , 10.1097/00000421-199112001-00008
Lee Ratner, Ethel Cesarman, Amy Chadburn, Ronald Mitsuyasu, , Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan, Alexandra M. Levine, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman, David Aboulafia, Ariela Noy, David H. Henry, Jamie Von Roenn, Bruce J. Dezube, Scot C. Remick, Manisha H. Shah, Lawrence Leichman, Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. ,vol. 115, pp. 3008- 3016 ,(2010) , 10.1182/BLOOD-2009-08-231613